# Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

> **NCT00927667** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 156 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **PROCEDURE:** No Drug
- **PROCEDURE:** No Drug
- **PROCEDURE:** No Drug
- **PROCEDURE:** No Drug
- **PROCEDURE:** No Drug

## Key facts

- **NCT ID:** NCT00927667
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927667, "Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00927667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*